| NKTR Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the NKTR shares outstanding history going back to 2/26/2010:
Also see: NKTR Market Cap History NKTR YTD Return |
NKTR Shares Outstanding History — Nektar Therapeutics Share Count Over Time
As of 5/1/2026 Nektar Therapeutics has 33.79 million NKTR shares outstanding. Investors often track the NKTR shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows NKTR share count trends over time, with 66 historical shares outstanding datapoints presented, dating back to 2/26/2010.
| NKTR Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NKTR Historical Shares Outstanding: +11.00% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NKTR Stock Price Chart |
| About Nektar Therapeutics |
| Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company. Co. is focused on discovering and developing medicines in the field of immunotherapy. Co. has a research and development pipeline of investigational medicines in immunology and oncology. In oncology, it is focused on developing medicines based on targeting biological pathways that stimulate and sustain the body's immune response to fight cancer. Its pipeline includes NKTR-255, Rezpegaldesleukin (REZPEG) and NKTR-0165. NKTR-255 is an investigational biologic that is designed to target the interleukin-15 (IL-15) pathway in order to activate the body's innate and adaptive immunity. We show 66 historical shares outstanding datapoints in our coverage of NKTR's shares outstanding history. Understanding the changing numbers of NKTR shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like NKTR versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching NKTR by allowing them to research NKTR shares outstanding history as well as any other stock in our coverage universe. |
| NKTR Current Stock Quote |
Quotes delayed 20 minutes  Free NKTR Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| NKTR Share Performance |
| Shares Outstanding Peers |
| Nektar Therapeutics (NKTR) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
NKTX Shares Outstanding History NLNK Shares Outstanding History NLTX Shares Outstanding History NMRA Shares Outstanding History NMRD Shares Outstanding History NMTC Shares Outstanding History NMTR Shares Outstanding History NOTV Shares Outstanding History NOVN Shares Outstanding History NPCE Shares Outstanding History More Healthcare companies » |
NKTR Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
